« All Blogs Feb 1, 2018
The Give and Take of the Cancer Registry
Cancer Registry

In my last blog post, I spoke about the cancer registry and how CHAMPS insight2oncology® (i2o®) is used to display its valuable information for hospital administrators and doctors in a comprehensive, easy-to-read format. Over the years, we have discovered that while the data available in the cancer registry is incredibly useful (I’ll get to that shortly), the quality is just as important, if not even MORE important, than the quantity

Through o2i, an administrator can view a five-year trend of colon cancer patient volumes at any given facility. However, if the data is not complete, the accuracy of that information can come into question. The methodical standards and quality checks, established by the CHAMPS Oncology team, help ensure everything revealed in i2o is accurate across the entire system. The importance of this is revealed in our client-based queries, as you will read below...


A good data set has a world of potential answers contained within it. What I never anticipated when I started using i2o, was the variety of questions and sources that would come up during overview sessions with our clients.

More and more physicians are coming to the data with queries that range from tumor recurrence to distribution of patients for a specific histology by age, stage and year of diagnosis. What we are finding is many doctors are just as interested in having direct feedback from the data regarding patterns of care, epidemiology and cancer care delivery for various treatment specialties (such as chemotherapy or radiation), and/or disease sites (such as breast or colon cancer). And while physicians are getting into the nitty gritty of a specific site category, administers are trying to determine the reach and depth of their care across each of their hospitals. Patient volumes, migration patterns and volumes by stage are constantly scrutinized for trends and anomalies. 


The most exciting thing about working with the various players in the hospital environment is learning how our i2o team can be an engaged partner in the continuum of cancer care. We are constantly growing and adjusting the number of reports displayed, as we make more and more use of the data available in the cancer registry. With each new data request, we are challenged to collaborate with our own programmers, cancer specialists, data analysts and certified tumor registrars to answer questions or assist with research that can slow down progress or be distracting at the hospital level. 

Because of our subject-matter expertise, analytics tool and access to the entirety of the cancer registry data set, we are able to nimbly provide feedback to queries on a moment’s notice. And we are just getting started. Stay tuned for my next blog post, where I’ll delve into some of the specific reports created in the last few months, as well as how and why they are used by our clients to make decisions for greater efficiency and growth.

Is your cancer registry data i2o-ready?

« Previous Blog Post CHAMPS: The Right Choice for Cancer Registry Management
Next Blog Post » Meet January’s Registry Rock Star: Marta Davis, BS
About the Author

Joseph Castellano

Joseph Castellano v3

10+ Years of Client Experience

ASK ME ABOUT | insight2oncology, Cancer Data & Analytics, Cancer Registry Operations, Strategic Planning, Client Relations, Contract Negotiations

See other articles by this author and view full bio »